# Trico Bancshares /: financial statements, quarterly

TCBK · Nasdaq · CIK 356171 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcbk.md) · [Financials](/companies/tcbk/financials.md) · [Filings](/companies/tcbk/filings.md) · [Insiders](/companies/tcbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tcbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.1](/filings/0000356171-24-000133.md) | [12.8 d](/filings/0000356171-26-000010.md) | [12.6](/filings/0001628280-25-024390.md) | [12.8](/filings/0001628280-25-039501.md) | [12.8](/filings/0000356171-25-000079.md) | [13.1 d](/filings/0000356171-26-000010.md) | [12.7](/filings/0000356171-26-000042.md) | [13.7](/filings/0000356171-26-000109.md) | [13.8](/filings/0000356171-25-000079.md) | [13.4 d](/filings/0000356171-26-000010.md) | [13.2](/filings/0000356171-26-000042.md) | [14.0](/filings/0000356171-26-000109.md) |
| Interest expense | $m | [24.3](/filings/0000356171-23-000061.md) | [29.3 d](/filings/0000356171-24-000012.md) | [32.7](/filings/0000356171-24-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.5](/filings/0000356171-24-000133.md) | [10.3 d](/filings/0000356171-26-000010.md) | [9.9](/filings/0001628280-25-024390.md) | [10.1](/filings/0001628280-25-039501.md) | [10.3](/filings/0000356171-25-000079.md) | [9.9 d](/filings/0000356171-26-000010.md) | [8.9](/filings/0000356171-26-000042.md) | [10.3](/filings/0000356171-26-000109.md) | [12.4](/filings/0000356171-25-000079.md) | [12.9 d](/filings/0000356171-26-000010.md) | [12.2](/filings/0000356171-26-000042.md) | [12.1](/filings/0000356171-26-000109.md) |
| Net income | $m | [30.6](/filings/0000356171-24-000133.md) | [26.1 d](/filings/0000356171-26-000010.md) | [27.7](/filings/0001628280-25-024390.md) | [29.0](/filings/0001628280-25-039501.md) | [29.1](/filings/0000356171-25-000079.md) | [29.0 d](/filings/0000356171-26-000010.md) | [26.4](/filings/0000356171-26-000042.md) | [27.5](/filings/0000356171-26-000109.md) | [34.0](/filings/0000356171-25-000079.md) | [33.6 d](/filings/0000356171-26-000010.md) | [33.7](/filings/0000356171-26-000042.md) | [34.2](/filings/0000356171-26-000109.md) |
| Diluted EPS | $ per share | [0.92](/filings/0000356171-24-000133.md) | not reported | [0.83](/filings/0001628280-25-024390.md) | [0.87](/filings/0001628280-25-039501.md) | [0.88](/filings/0000356171-25-000079.md) | not reported | [0.80](/filings/0000356171-26-000042.md) | [0.84](/filings/0000356171-26-000109.md) | [1.04](/filings/0000356171-25-000079.md) | not reported | [1.04](/filings/0000356171-26-000042.md) | [1.06](/filings/0000356171-26-000109.md) |
| Basic EPS | $ per share | [0.92](/filings/0000356171-24-000133.md) | not reported | [0.83](/filings/0001628280-25-024390.md) | [0.88](/filings/0001628280-25-039501.md) | [0.88](/filings/0000356171-25-000079.md) | not reported | [0.80](/filings/0000356171-26-000042.md) | [0.84](/filings/0000356171-26-000109.md) | [1.04](/filings/0000356171-25-000079.md) | not reported | [1.05](/filings/0000356171-26-000042.md) | [1.07](/filings/0000356171-26-000109.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0000356171-23-000061.md) | [98.7](/filings/0000356171-25-000012.md) | [82.8](/filings/0000356171-24-000020.md) | [207](/filings/0000356171-24-000102.md) | [320](/filings/0000356171-24-000133.md) | [145](/filings/0000356171-26-000010.md) | [308](/filings/0001628280-25-024390.md) | [314](/filings/0001628280-25-039501.md) | [299](/filings/0000356171-25-000079.md) | [157](/filings/0000356171-26-000109.md) | [301](/filings/0000356171-26-000042.md) | [105](/filings/0000356171-26-000109.md) |
| Total assets | $m | [9,897](/filings/0000356171-23-000061.md) | [9,910](/filings/0000356171-25-000012.md) | [9,814](/filings/0000356171-24-000020.md) | [9,741](/filings/0000356171-24-000102.md) | [9,824](/filings/0000356171-24-000133.md) | [9,674](/filings/0000356171-26-000010.md) | [9,820](/filings/0001628280-25-024390.md) | [9,924](/filings/0001628280-25-039501.md) | [9,879](/filings/0000356171-25-000079.md) | [9,822](/filings/0000356171-26-000109.md) | [9,948](/filings/0000356171-26-000042.md) | [9,931](/filings/0000356171-26-000109.md) |
| Total liabilities | $m | [8,827](/filings/0000356171-23-000061.md) | [8,750](/filings/0000356171-25-000012.md) | [8,651](/filings/0000356171-24-000020.md) | [8,566](/filings/0000356171-24-000102.md) | [8,585](/filings/0000356171-24-000133.md) | [8,453](/filings/0000356171-26-000010.md) | [8,564](/filings/0001628280-25-024390.md) | [8,657](/filings/0001628280-25-039501.md) | [8,575](/filings/0000356171-25-000079.md) | [8,494](/filings/0000356171-26-000109.md) | [8,624](/filings/0000356171-26-000042.md) | [8,587](/filings/0000356171-26-000109.md) |
| Shareholders' equity | $m | [1,070](/filings/0000356171-24-000133.md) | [1,160](/filings/0000356171-26-000010.md) | [1,163](/filings/0001628280-25-039501.md) | [1,175](/filings/0000356171-25-000079.md) | [1,239](/filings/0000356171-25-000079.md) | [1,221](/filings/0000356171-26-000109.md) | [1,256](/filings/0000356171-26-000109.md) | [1,267](/filings/0000356171-26-000109.md) | [1,304](/filings/0000356171-25-000079.md) | [1,328](/filings/0000356171-26-000109.md) | [1,324](/filings/0000356171-26-000109.md) | [1,344](/filings/0000356171-26-000109.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [46.2 d](/filings/0000356171-24-000133.md) | [36.5 d](/filings/0000356171-26-000010.md) | [25.1](/filings/0001628280-25-024390.md) | [31.8 d](/filings/0001628280-25-039501.md) | [28.6 d](/filings/0000356171-25-000079.md) | [24.2 d](/filings/0000356171-26-000010.md) | [24.5](/filings/0000356171-26-000042.md) | [29.2 d](/filings/0000356171-26-000109.md) | [45.1 d](/filings/0000356171-25-000079.md) | [34.5 d](/filings/0000356171-26-000010.md) | [33.7](/filings/0000356171-26-000042.md) | [25.1 d](/filings/0000356171-26-000109.md) |
| Capital expenditure | $m | [0.6 d](/filings/0000356171-24-000133.md) | [1.0 d](/filings/0000356171-26-000010.md) | [1.0](/filings/0001628280-25-024390.md) | [1.0 d](/filings/0001628280-25-039501.md) | [1.2 d](/filings/0000356171-25-000079.md) | [1.3 d](/filings/0000356171-26-000010.md) | [1.7](/filings/0000356171-26-000042.md) | [1.0 d](/filings/0000356171-26-000109.md) | [1.9 d](/filings/0000356171-25-000079.md) | [0.8 d](/filings/0000356171-26-000010.md) | [0.7](/filings/0000356171-26-000042.md) | [1.9 d](/filings/0000356171-26-000109.md) |
| Dividends paid | $m | [10.0 d](/filings/0000356171-24-000133.md) | [10.0 d](/filings/0000356171-26-000010.md) | [11.0](/filings/0001628280-25-024390.md) | [10.9 d](/filings/0001628280-25-039501.md) | [10.9 d](/filings/0000356171-25-000079.md) | [10.9 d](/filings/0000356171-26-000010.md) | [10.9](/filings/0000356171-26-000042.md) | [10.8 d](/filings/0000356171-26-000109.md) | [11.7 d](/filings/0000356171-25-000079.md) | [11.7 d](/filings/0000356171-26-000010.md) | [11.5](/filings/0000356171-26-000042.md) | [11.5 d](/filings/0000356171-26-000109.md) |
| Share repurchases | $m | [0.0 d](/filings/0000356171-24-000133.md) | [0.1 d](/filings/0000356171-26-000010.md) | [3.4](/filings/0001628280-25-024390.md) | [10.2 d](/filings/0001628280-25-039501.md) | [0.1 d](/filings/0000356171-25-000079.md) | [1.9 d](/filings/0000356171-26-000010.md) | [4.1](/filings/0000356171-26-000042.md) | [15.7 d](/filings/0000356171-26-000109.md) | [2.5 d](/filings/0000356171-25-000079.md) | [9.7 d](/filings/0000356171-26-000010.md) | [22.4](/filings/0000356171-26-000042.md) | [1.8 d](/filings/0000356171-26-000109.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.5](/filings/0000356171-23-000061.md) | [33.4](/filings/0000356171-24-000020.md) | [33.3](/filings/0000356171-24-000102.md) | [33.3](/filings/0000356171-24-000133.md) | [33.4](/filings/0001628280-25-024390.md) | [33.2](/filings/0001628280-25-039501.md) | [33.1](/filings/0000356171-25-000079.md) | [33.1](/filings/0000356171-26-000042.md) | [32.9](/filings/0000356171-26-000109.md) | [32.7](/filings/0000356171-25-000079.md) | [32.4](/filings/0000356171-26-000042.md) | [32.1](/filings/0000356171-26-000109.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,966,630 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0000356171-26-000109.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.